Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-04-23
2010-02-16
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S199000
Reexamination Certificate
active
07662836
ABSTRACT:
An indazole having analgesic activity, a method for the preparation thereof and a pharmaceutical composition containing the same; the indazole has the following general formula:where X, Ra, Rb, Rcand Rdhave the meanings stated in the description.
REFERENCES:
patent: 5654320 (1997-08-01), Catlow et al.
patent: 6017931 (2000-01-01), Silverman et al.
patent: 6096476 (2000-08-01), Yanagida et al.
patent: 6096746 (2000-08-01), Suzuki et al.
patent: 6197769 (2001-03-01), Alisi et al.
patent: 6770650 (2004-08-01), Gong et al.
patent: 908 459 (1999-04-01), None
patent: 975 623 (2000-02-01), None
patent: 98/07728 (1998-02-01), None
patent: 98/46589 (1998-10-01), None
patent: 03/004026 (2003-01-01), None
Schaus et al. “Synthesis and structure-activity relationships . . . ” J. Med. chem. v.41, p. 1943-1955 (1998).
Alisi et al. “preparation of indazoleamide . . . ” CA 129:316219 (1998).
Catlow et al. “Preparation of indazolecarboxamides . . . ” Ca 127:205575 (1997).
Patani et al. “bioisosterism: a rational approach in drug design” Che. Rev. v. 96, p. 3147-3176 (1996).
Englen et al. “Central 5HT4 receptors” Trends in pharmacol. sci. v.16(1111) p. 391-398 (1995).
Michael A. Ashburn et al, “Management of chronic pain”, The Lancet, vol. 353, pp. 1865-1869 May 29, 1999.
Edited by Patrick D. Wall et al, Textbook of Pain, 4thedition, Churchill Livingstone 1999.
Joachim Scholz et al., “Can we conquer pain?”, Nature Neuroscience Supplement, vol. 5, pp. 1062-1067 2002.
John D. Prugh et al., “A simple method of protecting a secondary amine with tert butyloxycarbonyl (boc) in the presence of a primary amine”, Synthetic Communications, vol. 22, No. 16, pp. 2357-2360 1992.
Charles E. Kwartler et al, “The preparation of sulfanilamidoindazoles”, J.A.C.S., vol. 65, pp. 1804-1806 1943.
Giorgio Corsi et al., “1-Halobenzyl-1H-indazole-3-carboxylic acids. A new class of antispermatogenic agents”, Journal of Medicinal Chemistry, vol. 19, No. 6, pp. 778-783 1976.
Aloke K. Dutta et al., “Structure-activity relationship studies of novel 4-[2-[bis(4-fluorophenyl]methoxy-ethyl]-1-(3-phenylpropyl)piperidine analogs: synthesis and biological evaluation at the dopamine and serotonin Transporter Sites”, Journal of Medicinal Chemistry, vol. 39, No. 3, pp. 749-756 1996.
Richard F. Smith et al., “Diindazolo[2,3-a, 2′,3′-d]pyrazine-7,14-dione”, J.O.C., vol. 23, p. 621 1958.
Nicolo Vivona et al., “Mononuclear heterocyclic rearrangements. part 12 (1). rearrangement of 1,2,4-oxadiazoles into indazoles”, Journal of Heterocyclic Chemistry, vol. 16, pp. 783-784 1979.
N.P. Buu-Hoi et al., “Indazole-3-carboxylic acids and their derivatives”, Journal of Heterocyclic Chemistry, vol. 1, No. 5, pp. 239-241 1964.
Richard C. Larock, “Comprehensive organic transformations”. VCH, pp. 965-966.
Lowell O. Randall et al., “A method for measurement of analgesic activity on inflamed tissue”, Arch. Int. Pharmacodyn. Ther., vol. 111, No. 4, pp. 409-419 1957.
David Andrew et al., “Mechanical and heat sensitization of cutaneous nociceptors after peripheral inflammation in the rat”, J. Neurophysiol, vol. 82, No. 5, pp. 2649-2656 1999.
K. Hargreaves, et al., “A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia”, Pain, vol. 32 pp. 77-88 1988.
C. Courteix et al., “Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain”, Pain, vol. 53, pp. 81-88 1993.
A. W. Bannon et al., “ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain”, Brain Research, vol. 801, pp. 158-163 1998.
U.S. Appl. No. 10/564,854, filed Jan. 17, 2006, Guglielmotti, et al.
Alisi Maria Alessandra
Cazzolla Nicola
Furlotti Guido
Guglielmotti Angelo
Polenzani Lorenzo
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
Chang Celia
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Indazole having analgesic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indazole having analgesic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazole having analgesic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4219661